Telomeres in cancer: tumour suppression and genome instability
Open accessAbstract
The shortening of human telomeres has two opposing effects during cancer development. On the one hand, telomere shortening can exert a tumour-suppressive effect through the proliferation arrest induced by activating the kinases ATM and ATR at unprotected chromosome ends. On the other hand, loss of telomere protection can lead to telomere crisis, which is a state of extensive genome instability that can promote cancer progression. Recent data, reviewed here, provide new evidence for the telomere tumour suppressor pathway and has revealed that telomere crisis can induce numerous cancer-relevant changes, including chromothripsis, kataegis and tetraploidization.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 101 cited sources checked · 0 supported · 0 flagged
- Interpretationnone given
Telomere shortening can suppress tumours by inducing proliferation arrest through ATM and ATR activation at unprotected chromosome ends.
“On the one hand, telomere shortening can exert a tumour-suppressive effect through the proliferation arrest induced by activating the kinases ATM and ATR at unprotected chromosome ends.”
Quote in the paperSubstantial claim - Premisecitation
Loss of telomere function at a few chromosome ends is sufficient to induce replicative arrest.
“Loss of telomere function at a few chromosome ends in a cell is sufficient to induce replicative arrest9,39,40 (FIG. 2b).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [9] Davoli, T. & de Lange, T. Telomere-driven tetraploidization occurs in human cells undergoing crisis and promotes transformation of mouse cells. Cancer Cell 21, 765–776 (2012). Reports that telomere-driven tetraploidy occurs in human cells during telomere crisis. source
Not checked in the free run.
- cites [39] d'Adda di Fagagna, F. et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426, 194–198 (2003). Finds that telomeres in senescent cells exhibit the hallmarks of DNA DSBs. source
Not checked in the free run.
- cites [40] Zou, Y., Sfeir, A., Gryaznov, S. M., Shay, J. W. & Wright, W. E. Does a sentinel or a subset of short telomeres determine replicative senescence? Mol. Biol. Cell 15, 3709–3718 (2004). source
Not checked in the free run.
- Interpretationnone given
Loss of telomere protection can cause telomere crisis, a state of extensive genome instability that can promote cancer progression.
“On the other hand, loss of telomere protection can lead to telomere crisis, which is a state of extensive genome instability that can promote cancer progression.”
Quote in the paperSubstantial claim - Premisecitation
In human cells without telomerase, telomeres shorten by 50-100 base pairs per population doubling.
“In the absence of telomerase, each human telomere shortens at a rate of 50–100 bps per population doubling29.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [29] Harley, C. B., Futcher, A. B. & Greider, C. W. Telomeres shorten during ageing of human fibroblasts. Nature 345, 458–460 (1990). Demonstrates that the telomeres of human fibroblasts shorten during growth in culture. source
Not checked in the free run.
- Interpretationnone given
Telomere crisis can induce cancer-relevant changes including chromothripsis, kataegis, and tetraploidization.
“Recent data, reviewed here, provide new evidence for the telomere tumour suppressor pathway and has revealed that telomere crisis can induce numerous cancer-relevant changes, including chromothripsis, kataegis and tetraploidization.”
Quote in the paperSubstantial claim
- Premisecitation
TERT silencing downregulates telomerase activity in human somatic cells.
“TERT silencing downregulates telomerase activity in human somatic cells (reviewed in REF. 22).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [22] Shay, J. W. Role of telomeres and telomerase in aging and cancer. Cancer Discov. 6, 584–593 (2016). source
Not checked in the free run.
- Premisecitation
A large melanoma-prone family study identified an activating TERT promoter mutation that co-segregates with disease predisposition.
“A linkage analysis and high-throughput sequencing identified an activating mutation in the TERT promoter that co-segregates with disease predisposition.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58] Horn, S. et al. TERT promoter mutations in familial and sporadic melanoma. Science 339, 959–961 (2013). Identifies activating mutations in the TERT promoter through an analysis of melanoma-prone families. source
Not checked in the free run.
- Premisecitation
Longer telomere length is associated with increased risk of B cell lymphoma and chronic lymphocytic leukaemia.
“Another observation in support of the telomere tumour suppressor pathway is that longer telomere length has been associated with an increased risk of B cell lymphoma and chronic lymphocytic leukaemia (CLL)65–67.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [65] Machiela, M. J. et al. Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never-smoking women in Asia: a report from the female lung cancer consortium in Asia. Int. J. Cancer 137, 311–319 (2015). Assesses telomere length using telomere length-associated single-nucleotide polymorphisms and finds that longer telomere length is associated with increased risk of non-Hodgkin lymphoma. source
Not checked in the free run.
- cites [66] Machiela, M. J. et al. Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes. Hum. Mol. Genet. 25, 1663–1676 (2016). source
Not checked in the free run.
- cites [67] Ojha, J. et al. Genetic variation associated with longer telomere length increases risk of chronic lymphocytic leukemia. Cancer Epidemiol. Biomarkers Prev. 25, 1043–1049 (2016). Shows that an inherited predisposition for longer telomeres is associated with an increased risk of CLL. source
Not checked in the free run.
- Premisecitation
Live-cell imaging showed that dicentric chromosomes formed during telomere crisis do not break during mitosis.
“This study used live-cell imaging to determine the fate of dicentric chromosomes formed during telomere crisis and showed that dicentric chromosomes do not break during mitosis.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Maciejowski, J., Li, Y., Bosco, N., Campbell, P. J. & de Lange, T. Chromothripsis and kataegis induced by telomere crisis. Cell 163, 1641–1654 (2015). Shows that dicentric chromosomes formed during telomere crisis persist through mitosis, are fragmented by TREX1 in G1 phase and give rise to chromothripsis and kataegis. source
Not checked in the free run.
- Premisecitation
Proof that replicative senescence is caused by telomere shortening came from bypassing senescence after TERT expression.
“Proof that replicative senescence is due to telomere shortening came from the bypass of senescence upon TERT expression23.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] Bodnar, A. G. et al. Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349–352 (1998). Establishes a causal relationship between telomere shortening and cellular senescence. source
Not checked in the free run.
- Premisecitation
In mice, p53 inactivation alone is sufficient to avoid telomere-induced senescence and apoptosis.
“By contrast, p53 inactivation alone is sufficient to avoid telomere-induced senescence and apoptosis in mice49,50.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [49] Chin, L. et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97, 527–538 (1999). Shows that p53 is activated during telomere crisis to induce growth arrest and suppress transformation. source
Not checked in the free run.
- cites [50] Smogorzewska, A. & de Lange, T. Different telomere damage signaling pathways in human and mouse cells. EMBO J. 21, 4338–4348 (2002). source
Not checked in the free run.
- Interpretationreasoning
Because human telomeres vary in size, cells with an apparently ample telomere reserve can contain several very short telomeres, making bulk telomere length an imprecise predictor of proliferative potential.
“Because human telomeres are heterogeneously sized, several very short telomeres can be present in cells with an apparently ample telomere reserve, which makes measurements of bulk telomere length an imprecise predictor of cellular proliferative potential.”
Quote in the paperSubstantial claim - Premisecitation
Crosses of telomerase-deficient mice with tumour model mice show that critically short telomeres limit tumour formation when the p53 pathway is functional.
“Crosses of telomerase-deficient mice with various tumour model mice have demonstrated that critically short telomeres limit tumour formation when the p53 pathway is functional51–55.”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [51] Greenberg, R. A. et al. Short dysfunctional telomeres impair tumorigenesis in the INK4aΔ2/3 cancer-prone mouse. Cell 97, 515–525 (1999). source
Not checked in the free run.
- cites [52] Rudolph, K. L., Millard, M., Bosenberg, M. W. & DePinho, R. A. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat. Genet. 28, 155–159 (2001). source
Not checked in the free run.
- cites [53] Qi, L. et al. Short telomeres and ataxia-telangiectasia mutated deficiency cooperatively increase telomere dysfunction and suppress tumorigenesis. Cancer Res. 63, 8188–8196 (2003).
Not checked in the free run.
- cites [54] Qi, L., Strong, M. A., Karim, B. O., Huso, D. L. & Greider, C. W. Telomere fusion to chromosome breaks reduces oncogenic translocations and tumour formation. Nat. Cell Biol. 7, 706–711 (2005). source
Not checked in the free run.
- cites [55] Feldser, D. M. & Greider, C. W. Short telomeres limit tumor progression in vivo by inducing senescence. Cancer Cell 11, 461–469 (2007). source
Not checked in the free run.
- Interpretationcitation
Activating mutations in the TERT promoter in several cancer types strongly argue that those tumours were selected for telomerase activation.
“The recent identification of activating mutations in the TERT promoter in several cancer types argues strongly that these tumours had undergone selection for the activation of telomerase57,58.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [57] Huang, F. W. et al. Highly recurrent TERT promoter mutations in human melanoma. Science 339, 957–959 (2013). Uses whole-genome sequencing in melanomas to identify activating mutations in the TERT promoter. source
Not checked in the free run.
- cites [58] Horn, S. et al. TERT promoter mutations in familial and sporadic melanoma. Science 339, 959–961 (2013). Identifies activating mutations in the TERT promoter through an analysis of melanoma-prone families. source
Not checked in the free run.
- Interpretationcitation
Complete bypass of telomere shortening-induced senescence in human cells requires inactivation of multiple pathways, making this proliferation barrier robust.
“Because the complete bypass of telomere shortening-induced senescence in human cells requires the inactivation of multiple pathways, this mechanism of curbing the proliferation of transformed cells is likely to be robust43,45–48.”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [43] Jacobs, J. J. L. & de Lange, T. Significant role for p16INK4a in p53-independent telomere-directed senescence. Curr. Biol. 14, 2302–2308 (2004). source
Not checked in the free run.
- cites [45] Shay, J. W., Pereira-Smith, O. M. & Wright, W. E. A role for both RB and p53 in the regulation of human cellular senescence. Exp. Cell Res. 196, 33–39 (1991). source
Not checked in the free run.
- cites [46] Hara, E., Tsurui, H., Shinozaki, A., Nakada, S. & Oda, K. Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. Biochem. Biophys. Res. Commun. 179, 528–534 (1991). source
Not checked in the free run.
- cites [47] Shay, J. W., Wright, W. E., Brasiskyte, D. & Van der Haegen, B. A. E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts. Oncogene 8, 1407–1413 (1993).
Not checked in the free run.
- cites [48] Brown, J. P., Wei, W. & Sedivy, J. M. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277, 831–834 (1997). source
Not checked in the free run.
- Premisecitation
Chromothripsis induced by experimental telomere crisis is often accompanied by kataegis.
“Chromothripsis induced by experimental telomere crisis is often accompanied by kataegis (FIG. 5c).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] Maciejowski, J., Li, Y., Bosco, N., Campbell, P. J. & de Lange, T. Chromothripsis and kataegis induced by telomere crisis. Cell 163, 1641–1654 (2015). Shows that dicentric chromosomes formed during telomere crisis persist through mitosis, are fragmented by TREX1 in G1 phase and give rise to chromothripsis and kataegis. source
Not checked in the free run.
- Premisecitation
The repertoire of genomic alterations attributable to telomere crisis is more extensive and includes whole-genome reduplication, chromothripsis, and kataegis.
“However, it has recently become clear that the repertoire of genomic alterations that can be ascribed to telomere crisis is more extensive and includes whole-genome reduplication, chromothripsis and kataegis3,8,9.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [3] Maciejowski, J., Li, Y., Bosco, N., Campbell, P. J. & de Lange, T. Chromothripsis and kataegis induced by telomere crisis. Cell 163, 1641–1654 (2015). Shows that dicentric chromosomes formed during telomere crisis persist through mitosis, are fragmented by TREX1 in G1 phase and give rise to chromothripsis and kataegis. source
Not checked in the free run.
- cites [8] Davoli, T., Denchi, E. L. & de Lange, T. Persistent telomere damage induces bypass of mitosis and tetraploidy. Cell 141, 81–93 (2010). Finds that persistent telomere dysfunction and consequent DNA damage signalling lead to bypass of mitosis and tetraploidization. source
Not checked in the free run.
- cites [9] Davoli, T. & de Lange, T. Telomere-driven tetraploidization occurs in human cells undergoing crisis and promotes transformation of mouse cells. Cancer Cell 21, 765–776 (2012). Reports that telomere-driven tetraploidy occurs in human cells during telomere crisis. source
Not checked in the free run.
- Premisecitation
The point at which telomere attrition causes loss of protection at one or a few ends depends on shortening rate, initial telomere length, and the length of the shortest telomeres.
“The point at which telomere attrition results in the loss of telomere protection at one or a few chromosome ends is dependent on the rate of telomere shortening, the initial telomere length and, importantly, the length of the shortest telomeres in the cells41.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [41] Hemann, M. T., Strong, M. A., Hao, L. Y. & Greider, C. W. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107, 67–77 (2001). source
Not checked in the free run.
- Premisecitation
The melanoma-predisposing TERT promoter mutation creates a binding motif for ETS transcription factors.
“This mutation (T>G; 57 bp upstream of the transcription start site) creates a binding motif for ETS (E26 transformation-specific) transcription factors.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58] Horn, S. et al. TERT promoter mutations in familial and sporadic melanoma. Science 339, 959–961 (2013). Identifies activating mutations in the TERT promoter through an analysis of melanoma-prone families. source
Not checked in the free run.
- Premisecitation
Telomere crisis can induce tetraploidization.
“Finally, telomere crisis can induce tetraploidization (doubling the set of chromosomes)8,9, which is inferred to be a frequent event during the development of human cancers125.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [8] Davoli, T., Denchi, E. L. & de Lange, T. Persistent telomere damage induces bypass of mitosis and tetraploidy. Cell 141, 81–93 (2010). Finds that persistent telomere dysfunction and consequent DNA damage signalling lead to bypass of mitosis and tetraploidization. source
Not checked in the free run.
- cites [9] Davoli, T. & de Lange, T. Telomere-driven tetraploidization occurs in human cells undergoing crisis and promotes transformation of mouse cells. Cancer Cell 21, 765–776 (2012). Reports that telomere-driven tetraploidy occurs in human cells during telomere crisis. source
Not checked in the free run.
- Premisereasoning
Melanoma-predisposing POT1 mutations reduce POT1 binding to single-stranded telomeric DNA.
“As a consequence, the ability of POT1 to bind to single-stranded telomeric DNA is diminished.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [62] Robles-Espinoza, C. D. et al. POT1 loss-of-function variants predispose to familial melanoma. Nat. Genet. 46, 478–481 (2014). Links germline, loss-of-function variants of POT1 to melanoma susceptibility and increased telomere length. source
Not checked in the free run.
- cites [63] Shi, J. et al. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma. Nat. Genet. 46, 482–486 (2014). Reports the identification of unrelated, melanoma-prone families that carry variants of POT1 and show increased telomere lengths. source
Not checked in the free run.
- Premisecitation
Genome instability in cells undergoing telomere crisis was initially found to cause aneuploidy, translocations, loss of heterozygosity, and regional amplification through breakage-fusion-bridge cycles.
“Genome instability in cells undergoing telomere crisis was initially found to give rise to chromosome gains and losses (aneuploidy), translocations, gene loss (manifested as loss of heterozygosity (LOH)) and regional amplification through breakage–fusion–bridge (BFB) cycles1,80,83.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [1] Artandi, S. E. et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406, 641–645 (2000). Demonstrates that telomere attrition in p53-mutant mice promotes epithelial cancers through the formation of chromosome rearrangements. source
Not checked in the free run.
- cites [80] Roger, L. et al. Extensive telomere erosion in the initiation of colorectal adenomas and its association with chromosomal instability. J. Natl Cancer Inst. 105, 1202–1211 (2013). source
Not checked in the free run.
- cites [83] Riboni, R. et al. Telomeric fusions in cultured human fibroblasts as a source of genomic instability. Cancer Genet. Cytogenet. 95, 130–136 (1997). source
Not checked in the free run.
- Premisecitation
Chromothripsis was demonstrated to result from telomere crisis induced by inactivation of TRF2 in p53-deficient and RB-deficient epithelial cells.
“Consistent with these associations, chromothripsis was demonstrated to be the result of telomere crisis induced by the inactivation of the shelterin subunit TRF2 in p53-deficient and RB-deficient epithelial cells3.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Maciejowski, J., Li, Y., Bosco, N., Campbell, P. J. & de Lange, T. Chromothripsis and kataegis induced by telomere crisis. Cell 163, 1641–1654 (2015). Shows that dicentric chromosomes formed during telomere crisis persist through mitosis, are fragmented by TREX1 in G1 phase and give rise to chromothripsis and kataegis. source
Not checked in the free run.
- Interpretationreasoning
Fragmentation of chromatin bridge DNA by TREX1 could explain the regional DNA breaks typical of chromothripsis because only the portion of the dicentric chromosome inside the bridge is attacked.
“Fragmentation of chromatin bridge DNA by TREX1 could explain the regional DNA breaks that are typical of chromothripsis because only the portion of the dicentric chromosome residing inside the chromatin bridge is attacked by TREX1.”
Quote in the paperSubstantial claim - Interpretationreasoning
Failure of transformed cells to undergo senescence can produce telomere crisis, during which the cell population does not expand.
“Although the telomere tumour suppressor pathway may be a powerful mechanism to limit cancer development, failure of transformed cells to undergo senescence can produce telomere crisis, during which the cell population does not expand.”
Quote in the paperNot a substantial claim - Premisecitation
Tetraploidization can be induced in cells lacking p53 and RB pathways that have a high load of dysfunctional telomeres.
“Tetraploidization can be induced in cells that lack the p53 and RB pathways, which have a high load of dysfunctional telomeres8,9 (FIG. 6).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [8] Davoli, T., Denchi, E. L. & de Lange, T. Persistent telomere damage induces bypass of mitosis and tetraploidy. Cell 141, 81–93 (2010). Finds that persistent telomere dysfunction and consequent DNA damage signalling lead to bypass of mitosis and tetraploidization. source
Not checked in the free run.
- cites [9] Davoli, T. & de Lange, T. Telomere-driven tetraploidization occurs in human cells undergoing crisis and promotes transformation of mouse cells. Cancer Cell 21, 765–776 (2012). Reports that telomere-driven tetraploidy occurs in human cells during telomere crisis. source
Not checked in the free run.
- Premisecitation
Senescent human fibroblasts show molecular hallmarks of an activated DDR, including ATM and ATR signalling and nuclear foci containing DNA damage markers such as γ-H2AX, 53BP1, and MDC1.
“Senescent human fibroblasts display the molecular hallmarks of an activated DDR39, including ATM and ATR signalling, and nuclear foci containing DNA damage markers, such as γ-H2AX, p53-binding protein 1 (53BP1) and mediator of DNA damage checkpoint protein 1 (MDC1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [39] d'Adda di Fagagna, F. et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426, 194–198 (2003). Finds that telomeres in senescent cells exhibit the hallmarks of DNA DSBs. source
Not checked in the free run.
- Interpretationreasoning
Collectively, the data are consistent with telomere shortening functioning as a tumour suppressor pathway.
“Collectively, these data are consistent with telomere shortening functioning as a tumour suppressor pathway.”
Quote in the paperSubstantial claim - Premisecitation
When telomeres are compromised by loss of TRF2, their repair is carried out by c-NHEJ.
“By contrast, when telomeres are compromised through the loss of TRF2, their repair is carried out by c-NHEJ80–82.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [80] Roger, L. et al. Extensive telomere erosion in the initiation of colorectal adenomas and its association with chromosomal instability. J. Natl Cancer Inst. 105, 1202–1211 (2013). source
Not checked in the free run.
- cites [81] Celli, G. B. & de Lange, T. DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nat. Cell Biol. 7, 712–718 (2005). source
Not checked in the free run.
- cites [82] Celli, G. B., Denchi, E. L. & de Lange, T. Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination. Nat. Cell Biol. 8, 885–890 (2006). source
Not checked in the free run.
- Premisecitation
A significant minority of cancers use alternative lengthening of telomeres (ALT) to maintain telomeres.
“Furthermore, although most human cancers (~90%) escape telomere crisis by activating telomerase56, a significant minority of cancers use an alternative telomere maintenance system, referred to as alternative lengthening of telomeres (ALT)161.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [161] Pickett, H. A. & Reddel, R. R. Molecular mechanisms of activity and derepression of alternative lengthening of telomeres. Nat. Struct. Mol. Biol. 22, 875–880 (2015). source
Not checked in the free run.
- Premisecitation
In glioblastomas, sporadic TERT mutations activate transcription by recruiting GABPA.
“In glioblastomas, sporadic TERT mutations were shown to activate transcription by enabling the recruitment of the transcription factor GA-binding protein α-chain (GABPA)160.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [160] Bell, R. J. A. et al. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer. Science 348, 1036–1039 (2015). source
Not checked in the free run.
- Premisecitation
Shorter telomeres are frequently observed in cancer relative to adjacent normal tissue.
“Shorter telomeres are frequently observed in cancer relative to their adjacent normal tissue135–142.”
Quote in the paperSubstantial claim0 of 8 sources checked- cites [135] de Lange, T. et al. Structure and variability of human chromosome ends. Mol. Cell. Biol. 10, 518–527 (1990). source
Not checked in the free run.
- cites [136] Hastie, N. D. et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 346, 866–868 (1990). source
Not checked in the free run.
- cites [137] Furugori, E. et al. Telomere shortening in gastric carcinoma with aging despite telomerase activation. J. Cancer Res. Clin. Oncol. 126, 481–485 (2000). source
Not checked in the free run.
- cites [138] Mehle, C., Ljungberg, B. & Roos, G. Telomere shortening in renal cell carcinoma. Cancer Res. 54, 236–241 (1994).
Not checked in the free run.
- cites [139] Takagi, S. et al. Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas. Cancer 86, 1431–1436 (1999). source
Not checked in the free run.
- cites [140] Sommerfeld, H. J. et al. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res. 56, 218–222 (1996).
Not checked in the free run.
- cites [141] Meeker, A. K. et al. Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis. Cancer Res. 62, 6405–6409 (2002).
Not checked in the free run.
- cites [142] Meeker, A. K. et al. Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin. Cancer Res. 10, 3317–3326 (2004). source
Not checked in the free run.
- Premisecitation
In CLL and invasive ductal carcinoma of the breast, overall survival is shorter when telomeres are in a size range expected to result in telomere fusions.
“In CLL and invasive ductal carcinoma of the breast, overall survival is shorter when the telomeres are in a size range expected to result in telomere fusions151,152.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [151] Lin, T. T. et al. Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage disease. Br. J. Haematol. 167, 223 (2014).
Not checked in the free run.
- cites [152] Simpson, K. et al. Telomere fusion threshold identifies a poor prognostic subset of breast cancer patients. Mol. Oncol. 9, 1186–1193 (2015). source
Not checked in the free run.
- Premisecitation
Most human cancers (~90%) escape telomere crisis by activating telomerase.
“Furthermore, although most human cancers (~90%) escape telomere crisis by activating telomerase56, a significant minority of cancers use an alternative telomere maintenance system, referred to as alternative lengthening of telomeres (ALT)161.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56] Kim, N. W. et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011–2015 (1994). source
Not checked in the free run.
- Interpretationcitation
The transient nature of telomere crisis as a source of genome instability in cancer is attractive because it avoids a persistent mutator phenotype that could hamper cell proliferation.
“The brief, or at least transient, episode of genomic instability offered by dysfunctional telomeres avoids a persistent mutator phenotype that might hamper cell proliferation10.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] de Lange, T. Telomere-related genome instability in cancer. Cold Spring Harb. Symp. Quant. Biol. 70, 197–204 (2005). source
Not checked in the free run.
- Rests on an assumption: Most mutations are deleterious to cellular fitness.
- Premisecitation
Telomere loss at individual chromosome ends is sufficient to produce many rearrangements seen in telomere crisis and cancer, including amplifications, LOH, translocations, chromosome non-disjunction, and formation of isochromosomes and ring chromosomes.
“Telomere loss at individual chromosome ends is sufficient to produce many of the rearrangements seen in telomere crisis and in cancer, including amplifications, LOH, translocations, chromosome non-disjunction during mitosis, and the formation of isochromosomes and ring chromosomes170,172.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [170] Fouladi, B., Sabatier, L., Miller, D., Pottier, G. & Murnane, J. P. The relationship between spontaneous telomere loss and chromosome instability in a human tumor cell line. Neoplasia 2, 540–554 (2000). source
Not checked in the free run.
- cites [172] Sabatier, L., Ricoul, M., Pottier, G. & Murnane, J. P. The loss of a single telomere can result in instability of multiple chromosomes in a human tumor cell line. Mol. Cancer Res. 3, 139–150 (2005). source
Not checked in the free run.
- Interpretationcitation
Even limited telomere dysfunction can cause widespread genome instability because instability at individual chromosome ends can transfer to other chromosomes through non-reciprocal translocations.
“Even limited telomere dysfunction can wreak havoc on the genome because instability at individual chromosome ends can be transferred to other chromosomes through non-reciprocal translocations172,173.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [172] Sabatier, L., Ricoul, M., Pottier, G. & Murnane, J. P. The loss of a single telomere can result in instability of multiple chromosomes in a human tumor cell line. Mol. Cancer Res. 3, 139–150 (2005). source
Not checked in the free run.
- cites [173] Gascoigne, K. E. & Cheeseman, I. M. Induced dicentric chromosome formation promotes genomic rearrangements and tumorigenesis. Chromosome Res. 21, 407–418 (2013). source
Not checked in the free run.
- Premisecitation
Telomerase activation is often accomplished through mutations in the TERT promoter.
“Telomerase activation is often accomplished through mutations in the TERT promoter57,58.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [57] Huang, F. W. et al. Highly recurrent TERT promoter mutations in human melanoma. Science 339, 957–959 (2013). Uses whole-genome sequencing in melanomas to identify activating mutations in the TERT promoter. source
Not checked in the free run.
- cites [58] Horn, S. et al. TERT promoter mutations in familial and sporadic melanoma. Science 339, 959–961 (2013). Identifies activating mutations in the TERT promoter through an analysis of melanoma-prone families. source
Not checked in the free run.
- Premisecitation
Telomeres in human cancer are often shorter than in normal tissues.
“Telomeres in human cancer are often shorter than in normal tissues135.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [135] de Lange, T. et al. Structure and variability of human chromosome ends. Mol. Cell. Biol. 10, 518–527 (1990). source
Not checked in the free run.
- Interpretationreasoning
Telomere crisis may be a frequent event during the development of human epithelial cancers, which initially lack telomerase.
“Telomere crisis may be a frequent event during the development of human epithelial cancers, which initially lack telomerase.”
Quote in the paperSubstantial claim - Premisecitation
An analysis suggests that transition through telomere crisis in breast cancer occurs during progression from usual ductal hyperplasia to ductal carcinoma in situ.
“An analysis of genome instability and other features associated with telomere crisis, including anaphase and chromatin bridges, suggests that transition through telomere crisis in breast cancer occurs during progression from usual ductal hyperplasia (UDH) to ductal carcinoma in situ (DCIS)145.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [145] Chin, K. et al. In situ analyses of genome instability in breast cancer. Nat. Genet. 36, 984–988 (2004). source
Not checked in the free run.
- Premisecitation
Evidence for past telomere crisis has been obtained in chronic lymphocytic leukaemia, breast cancer, colorectal adenomas, and other solid tumours using a PCR-based assay for telomere-telomere fusions.
“Using this approach, evidence for past telomere crisis has been obtained in CLL as well as in breast cancer, colorectal adenomas and other solid tumours75,77,78.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [75] Capper, R. et al. The nature of telomere fusion and a definition of the critical telomere length in human cells. Genes Dev. 21, 2495–2508 (2007). source
Not checked in the free run.
- cites [77] Lin, T. T. et al. Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis. Blood 116, 1899–1907 (2010). Shows that telomere shortening and fusions in CLL increase with advanced disease and correlate with large-scale genome rearrangements. source
Not checked in the free run.
- cites [78] Jones, R. E. et al. Escape from telomere-driven crisis is DNA ligase III dependent. Cell Rep. 8, 1063–1076 (2014). source
Not checked in the free run.
- Premisecitation
ALT is associated with mutations in ATRX in vitro and in several human cancers, including glioblastomas.
“ALT is associated with mutations in the chromatin remodeller α-thalassaemia/mental retardation syndrome X-linked (AT R X ) both in vitro and in several human cancers, including glioblastomas162–165.”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [162] Lovejoy, C. A. et al. Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet. 8, e1002772 (2012). source
Not checked in the free run.
- cites [163] Schwartzentruber, J. et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482, 226–231 (2012). source
Not checked in the free run.
- cites [164] Heaphy, C. M. et al. Altered telomeres in tumors with ATRX and DAXX mutations. Science 333, 425 (2011). source
Not checked in the free run.
- cites [165] Heaphy, C. M. et al. Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am. J. Pathol. 179, 1608–1615 (2011). source
Not checked in the free run.
- May combine two claims. 20
May combine two claims.
PremisecitationTelomerase activation and telomere-length maintenance allow bypass of senescence and lead to cell immortalization.
“Telomerase activation and the resulting telomere-length maintenance leads to the bypass of senescence and ultimately to cell immortalization23,26,27.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [23] Bodnar, A. G. et al. Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349–352 (1998). Establishes a causal relationship between telomere shortening and cellular senescence. source
Not checked in the free run.
- cites [26] Ramirez, R. D. et al. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev. 15, 398–403 (2001). source
Not checked in the free run.
- cites [27] Vaziri, H. & Benchimol, S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8, 279–282 (1998). source
Not checked in the free run.
May combine two claims.
PremisecitationThe programmed silencing of TERT, loss of telomerase activity, and telomere shortening is not universal in mammals; it appears restricted to large animals with long lifespan.
“The programmed silencing of TERT, loss of telomerase activity and the resulting shortening of telomeres is not a universal phenomenon in mammals. Apparently, this tumour suppressor pathway is restricted to large animals with a reproductive strategy that requires a long lifespan28.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [28] Gomes, N. M. V. et al. Comparative biology of mammalian telomeres: hypotheses on ancestral states and the roles of telomeres in longevity determination. Aging Cell 10, 761–768 (2011). source
Not checked in the free run.
May combine two claims.
PremisecitationTREX1 creates extensive single-stranded DNA in chromatin bridges, leading to accumulation of RPA on the bridges.
“The exonuclease creates extensive single-stranded DNA in chromatin bridges, leading to an accumulation of the single-stranded DNA-binding protein replication protein A (RPA) on the bridges (FIG. 5b).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Maciejowski, J., Li, Y., Bosco, N., Campbell, P. J. & de Lange, T. Chromothripsis and kataegis induced by telomere crisis. Cell 163, 1641–1654 (2015). Shows that dicentric chromosomes formed during telomere crisis persist through mitosis, are fragmented by TREX1 in G1 phase and give rise to chromothripsis and kataegis. source
Not checked in the free run.
May combine two claims.
InterpretationreasoningBecause increased telomere length is present at birth, POT1 mutations likely delay senescence and postpone the tumour-suppressive effects of telomere attrition to a point of irrelevance.
“Because the increased telomere length is present at birth, these mutations are likely to push the onset of senescence to later population doublings, thus postponing the tumour-suppressive effects of telomere attrition to a point of irrelevance.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationTelomere fusions formed during telomere crisis in cultured cells are mediated by alt-NHEJ and show insertion of new sequences at the fusion point.
“Telomere fusions formed during telomere crisis in cultured cells are mediated by alt-NHEJ and exhibit insertion of new sequences at the fusion point75,76.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [75] Capper, R. et al. The nature of telomere fusion and a definition of the critical telomere length in human cells. Genes Dev. 21, 2495–2508 (2007). source
Not checked in the free run.
- cites [76] Oh, S. et al. DNA ligase III and DNA ligase IV carry out genetically distinct forms of end joining in human somatic cells. DNA Repair 21, 97–110 (2014). source
Not checked in the free run.
May combine two claims.
PremisecitationKataegis is found at the breakpoints of chromothriptic rearrangements created by telomere crisis, consistent with APOBEC activity.
“Consistent with APOBEC activity, kataegis is found at the breakpoints of chromothriptic rearrangements created by telomere crisis3.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] Maciejowski, J., Li, Y., Bosco, N., Campbell, P. J. & de Lange, T. Chromothripsis and kataegis induced by telomere crisis. Cell 163, 1641–1654 (2015). Shows that dicentric chromosomes formed during telomere crisis persist through mitosis, are fragmented by TREX1 in G1 phase and give rise to chromothripsis and kataegis. source
Not checked in the free run.
May combine two claims.
PremisereasoningCells in telomere crisis have end-to-end fused dicentric chromosomes, which cause mitotic mis-segregation and genomic instability.
“Consequently, cells in telomere crisis have end-to-end fused dicentric chromosomes, which lead to mitotic mis-segregation and genomic instability.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationTissues expressing ETS transcription factors are predicted to maintain telomerase activity and telomere length, disrupting the telomere tumour suppressor pathway.
“Thus, tissues that express ETS transcription factors are predicted to maintain telomerase activity, presumably resulting in the maintenance of telomere length and the consequent disruption of the telomere tumour suppressor pathway.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58] Horn, S. et al. TERT promoter mutations in familial and sporadic melanoma. Science 339, 959–961 (2013). Identifies activating mutations in the TERT promoter through an analysis of melanoma-prone families. source
Not checked in the free run.
May combine two claims.
PremisecitationDicentric chromosomes persist through mitosis and form long chromatin bridges that connect daughter cells into the next G1 phase.
“These dicentric chromosomes invariably persist through mitosis and form long chromatin bridges that connect the daughter cells well into the next G1 phase3.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Maciejowski, J., Li, Y., Bosco, N., Campbell, P. J. & de Lange, T. Chromothripsis and kataegis induced by telomere crisis. Cell 163, 1641–1654 (2015). Shows that dicentric chromosomes formed during telomere crisis persist through mitosis, are fragmented by TREX1 in G1 phase and give rise to chromothripsis and kataegis. source
Not checked in the free run.
May combine two claims.
PremisecitationInactivation of shelterin activates DNA damage signalling, upregulates p21 and p16, and causes DDR factors to accumulate at telomeres, linking telomere dysfunction to senescence.
“The inactivation of shelterin similarly activates DNA damage signalling pathways, results in the upregulation of p21 and p16, and leads to the accumulation of DDR factors at telomeres, thus linking telomere dysfunction and senescence39,42.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [39] d'Adda di Fagagna, F. et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426, 194–198 (2003). Finds that telomeres in senescent cells exhibit the hallmarks of DNA DSBs. source
Not checked in the free run.
- cites [42] Takai, H., Smogorzewska, A. & de Lange, T. DNA damage foci at dysfunctional telomeres. Curr. Biol. 13, 1549–1556 (2003). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningCarriers of POT1 mutations have longer telomeres, likely because POT1-mediated inhibition of telomerase is lost.
“Carriers of these mutations have longer telomeres, presumably owing to the loss of POT1-mediated inhibition of telomerase (BOX 1).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [62] Robles-Espinoza, C. D. et al. POT1 loss-of-function variants predispose to familial melanoma. Nat. Genet. 46, 478–481 (2014). Links germline, loss-of-function variants of POT1 to melanoma susceptibility and increased telomere length. source
Not checked in the free run.
- cites [63] Shi, J. et al. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma. Nat. Genet. 46, 482–486 (2014). Reports the identification of unrelated, melanoma-prone families that carry variants of POT1 and show increased telomere lengths. source
Not checked in the free run.
May combine two claims.
PremisecitationIn 95,568 individuals from the general population, genetic determinants of long telomeres are associated with increased overall cancer risk, especially lung cancer and melanoma.
“This analysis found that genetic determinants of long telomeres are associated with an increased overall cancer risk, especially lung cancer and melanoma.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [70] Rode, L., Nordestgaard, B. G. & Bojesen, S. E. Long telomeres and cancer risk among 95 568 individuals from the general population. Int. J. Epidemiol. 45, 1634–1643 (2016). source
Not checked in the free run.
May combine two claims.
InterpretationcitationOverexpression of TRF2 can delay senescence, indicating that the DDR in senescence results from insufficient shelterin loading at shortened telomeres.
“Furthermore, over-expression of the shelterin subunit telomeric repeat-binding factor 2 (TRF2; also known as TERF2) can delay the onset of senescence44, arguing that the DDR in senescence is due to an insufficient loading of shelterin at the shortened telomeres.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44] Karlseder, J., Smogorzewska, A. & de Lange, T. Senescence induced by altered telomere state, not telomere loss. Science 295, 2446–2449 (2002). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningTelomerase reactivation provides a route out of telomere crisis, stabilizing the genome and rescuing cellular fitness.
“Ultimately, telomerase reactivation provides a route out of telomere crisis, stabilizing the genome and rescuing cellular fitness.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationTERT promoter mutations are the most common non-coding mutations in cancer and are found in a growing list of cancers.
“These mutations are the most common mutations in non-coding sequences in cancer and are found in a long, and almost certainly growing, list of cancers153–158.”
Quote in the paperNot a substantial claim0 of 6 sources checked- cites [153] Heidenreich, B., Rachakonda, P. S., Hemminki, K. & Kumar, R. TERT promoter mutations in cancer development. Curr. Opin. Genet. Dev. 24, 30–37 (2014). source
Not checked in the free run.
- cites [154] Killela, P. J. et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc. Natl Acad. Sci. USA 110, 6026 (2013). source
Not checked in the free run.
- cites [155] Kinde, I. et al. TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine. Cancer Res. 73, 7162–7167 (2013). source
Not checked in the free run.
- cites [156] Remke, M. et al. TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol. 126, 917–929 (2013). source
Not checked in the free run.
- cites [157] Quaas, A. et al. Frequency of TERT promoter mutations in primary tumors of the liver. Virchows Arch. 465, 673–677 (2014). source
Not checked in the free run.
- cites [158] Weinhold, N., Jacobsen, A., Schultz, N., Sander, C. & Lee, W. Genome-wide analysis of noncoding regulatory mutations in cancer. Nat. Genet. 46, 1160–1165 (2014). source
Not checked in the free run.
May combine two claims.
PremisecitationIn urothelial cancers, TERT promoter mutations correlate with higher TERT mRNA and protein levels, enzymatic activity, and greater telomere length.
“An analysis of these mutations in urothelial cancers showed that they are correlated with higher levels of TERT mRNA and protein levels and enzymatic activity and with greater telomere length159.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [159] Borah, S. et al. TERT promoter mutations and telomerase reactivation in urothelial cancer. Science 347, 1006–1010 (2015). source
Not checked in the free run.
May combine two claims.
PremisecitationIn colorectal cancer, telomere fusion occurs during the adenoma-carcinoma transition and may also be present before most somatic mutations.
“In colorectal cancer, telomere fusion occurs during the adenoma–carcinoma transition and may also be present before the occurrence of most somatic mutations78.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [78] Jones, R. E. et al. Escape from telomere-driven crisis is DNA ligase III dependent. Cell Rep. 8, 1063–1076 (2014). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe mechanism of tetraploidization involves persistent ATM/ATR signalling from irreparably damaged telomeres, prolonged G2, bypass of mitosis, entry into a G1-like state, and a second S phase causing whole-genome reduplication.
“The mechanism of tetraploidization involves persistent ATM-dependent and/or ATR-dependent signalling induced by irreparably damaged telomeres. This signalling leads to a prolonged G2 phase and ultimately a bypass of mitosis and entry into a G1-like state. A second S phase then results in whole-genome reduplication and tetraploidy.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn mouse models, continued telomere dysfunction can constrain cancer progression, whereas telomerase reactivation alleviates intratumoural DNA damage and leads to more aggressive tumour progression and metastasis.
“In mouse models, continued telomere dysfunction can constrain cancer progression, whereas telomerase reactivation alleviates intratumoural DNA damage and leads to more aggressive tumour progression and metastasis168.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [168] Ding, Z. et al. Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases. Cell 148, 896–907 (2012). source
Not checked in the free run.
May combine two claims.
InterpretationcitationTERT promoter mutations are usually mutually exclusive with ATRX mutations, supporting the notion that ALT provides a telomerase-independent escape from telomere crisis.
“The observations that TERT promoter mutations are usually mutually exclusive with mutations in ATRX support the notion that ALT may provide a telomerase-independent escape from telomere crisis166,167.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [166] Ceccarelli, M. et al. Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell 164, 550–563 (2016). source
Not checked in the free run.
- cites [167] Eckel-Passow, J. E. et al. Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors. N. Engl. J. Med. 372, 2499–2508 (2015). source
Not checked in the free run.
The authors state this as an assumption.
The loss of viability in telomere crisis is driven by chromosome breakage and mis-segregation.
“A common assumption is that this loss of viability is driven by chromosome breakage and mis-segregation, although it may also involve additional telomere deprotection during an extended mitotic arrest that occurs in some of the cells71,72.”
The authors state this as an assumption.
Repair of the fragmented dicentric chromosome occurs during the cell cycle in which the RPA mark dissipates.
“As the RPA mark usually dissipates within one cell cycle, repair of the fragmented dicentric chromosome is presumed to occur during this period3.”
The paper relies on this without support.
Most mutations are deleterious to cellular fitness.
“However, persistence of a mutator phenotype comes at a cost because most mutations are deleterious to cellular fitness.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
TERC is ubiquitously expressed in various human cells, and TERT is suppressed in order to prevent uncontrolled cell replication.
“Despite this, TERC is ubiquitously expressed in various human cells, and TERT is suppressed in order to prevent uncontrolled cell replication [176].”
From Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy (2024) · cites this paper as [176]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Telomerase is described as both required and optional for escape from crisis
MinorThe paper says escape from telomere crisis requires telomerase activation, but later describes ALT as a telomerase-independent route out of the same crisis.
“The escape from telomere crisis requires the activation of telomerase, which reconstitutes telomere function and restores proliferative capacity.”
“The observations that TERT promoter mutations are usually mutually exclusive with mutations in ATRX support the notion that ALT may provide a telomerase-independent escape from telomere crisis166,167.”
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · see citing works
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750 · see citing works
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975 · see citing works
The landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017 · see citing works
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,855 · see citing works
Whole genomes redefine the mutational landscape of pancreatic cancer
Initiative, A. P. C. G., Waddell, N., Pajic, M., Patch, A.-M., Chang, D. K., Kassahn, K. S., Bailey, P., Johns, A. L., Miller, D., Nones, K., et al. (2015) · Nature · doi:10.1038/nature14169 · Cited by 2,642 · see citing works
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., et al. (2012) · Nature · doi:10.1038/nature10833 · Cited by 2,631 · see citing works
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414 · see citing works
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256 · see citing works
The RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227 · see citing works
Ceccarelli, M., Barthel, F. P., Malta, T. M., Sabedot, T. S., Salama, S. R., Murray, B. A., Morozova, O., Newton, Y., Radenbaugh, A., Pagnotta, S. M., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.028 · Cited by 2,178 · see citing works
Glioma Groups Based on 1p/19q, IDH , and TERT Promoter Mutations in Tumors
Eckel‐Passow, J. E., Lachance, D. H., Molinaro, A. M., Walsh, K. M., Decker, P. A., Sicotte, H., Pekmezci, M., Rice, T., Kosel, M., Smirnov, I. V., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1407279 · Cited by 1,981 · see citing works
Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions
Guelen, L., Pagie, L., Brasset, É., Meuleman, W. R. A., Faza, M. B., Talhout, W., Eussen, B. H. J., de Klein, A., Wessels, L. F. A., de Laat, W. L., et al. (2008) · Nature · doi:10.1038/nature06947 · Cited by 1,959 · see citing works
Mutational Processes Molding the Genomes of 21 Breast Cancers
Nik-Zainal, S., Alexandrov, L. B., Wedge, D. C., Van Loo, P., Greenman, C. D., Raine, K., Jones, D., Hinton, J., Marshall, J., Stebbings, L. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.024 · Cited by 1,909 · see citing works
Pan-cancer patterns of somatic copy number alteration
Zack, T. I., Schumacher, S. E., Carter, S. L., Cherniack, A. D., Saksena, G., Tabak, B., Lawrence, M. S., Zhang, C., Wala, J. A., Mermel, C. H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2760 · Cited by 1,843 · see citing works
Highly Recurrent <i>TERT</i> Promoter Mutations in Human Melanoma
Huang, F. W., Hodis, E., Xu, M. J., Kryukov, G. V., Chin, L., & Garraway, L. A. (2013) · Science · doi:10.1126/science.1229259 · Cited by 1,816 · see citing works
How Shelterin Protects Mammalian Telomeres
Palm, W., & de Lange, T. (2008) · Annual Review of Genetics · doi:10.1146/annurev.genet.41.110306.130350 · Cited by 1,802 · see citing works
Self-citation<i>TERT</i> Promoter Mutations in Familial and Sporadic Melanoma
Horn, S., Figl, A., Rachakonda, P. S., Fischer, C., Sucker, A., Gast, A., Kadel, S., Moll, I., Nagore, E., Hemminki, K., et al. (2013) · Science · doi:10.1126/science.1230062 · Cited by 1,799 · see citing works
Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784 · see citing works
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650 · see citing works
DNA Damage Foci at Dysfunctional Telomeres
Takai, H., Smogorzewska, A., & de Lange, T. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00542-6 · Cited by 1,409 · see citing works
Self-citationKillela, P. J., Reitman, Z. J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L. A., Friedman, A. H., Friedman, H., Gallia, G. L., Giovanella, B. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303607110 · Cited by 1,368 · see citing works
Nuclear envelope rupture and repair during cancer cell migration
Denais, C. M., Gilbert, R. M., Isermann, P., McGregor, A. L., te Lindert, M., Weigelin, B., Davidson, P. M., Friedl, P., Wolf, K., & Lammerding, J. (2016) · Science · doi:10.1126/science.aad7297 · Cited by 1,318 · see citing works
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., et al. (2010) · Nature · doi:10.1038/nature09460 · Cited by 1,317 · see citing works
Punctuated Evolution of Prostate Cancer Genomes
Baca, S. C., Prandi, D., Lawrence, M. S., Mosquera, J. M., Romanel, A., Drier, Y., Park, K., Kitabayashi, N., MacDonald, T. Y., Ghandi, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.021 · Cited by 1,300 · see citing works
Reverse Transcriptase Motifs in the Catalytic Subunit of Telomerase
Lingner, J., Hughes, T. R., Shevchenko, A., Mann, M., Lundblad, V., & Cech, T. R. (1997) · Science · doi:10.1126/science.276.5312.561 · Cited by 1,269 · see citing works
DNA breaks and chromosome pulverization from errors in mitosis
Crasta, K., Ganem, N. J., Dagher, R., Lantermann, A. B., Ivanova, E. V., Pan, Y., Nezi, L., Protopopov, A., Chowdhury, D., & Pellman, D. (2012) · Nature · doi:10.1038/nature10802 · Cited by 1,227 · see citing works
Hemann, M. T., Strong, M. A., Hao, L.-Y., & Greider, C. W. (2001) · Cell · doi:10.1016/s0092-8674(01)00504-9 · Cited by 1,219 · see citing works
Chromothripsis from DNA damage in micronuclei
Zhang, C., Spektor, A., Cornils, H., Francis, J. M., Jackson, E. K., Liu, S., Meyerson, M. M., & Pellman, D. S. (2015) · Nature · doi:10.1038/nature14493 · Cited by 1,153 · see citing works
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers
Roberts, S. A., Lawrence, M. S., Klimczak, L. J., Grimm, S. A., Fargo, D. C., Stojanov, P., Kieżun, A., Kryukov, G. V., Carter, S. L., Saksena, G., et al. (2013) · Nature Genetics · doi:10.1038/ng.2702 · Cited by 1,145 · see citing works
Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
Artandi, S. E., Chang, S., Lee, S.-L., Alson, S., Gottlieb, G. J., Chin, L., & DePinho, R. A. (2000) · Nature · doi:10.1038/35020592 · Cited by 1,085 · see citing works
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
Heaphy, C. M., de Wilde, R. F., Jiao, Y., Klein, A. P., Edil, B. H., Shi, C., Bettegowda, C., Rodriguez, F. J., Eberhart, C. G., Hebbar, S., et al. (2011) · Science · doi:10.1126/science.1207313 · Cited by 1,083 · see citing works
Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells
Fujiwara, T., Bandi, M., Nitta, M., Ivanova, E. V., Bronson, R. T., & Pellman, D. (2005) · Nature · doi:10.1038/nature04217 · Cited by 1,067 · see citing works
Vaziri, H., & Benchimol, S. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70109-5 · Cited by 1,003 · see citing works
Chin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S.-L., Gottlieb, G. J., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80762-x · Cited by 979 · see citing works
ESCRT III repairs nuclear envelope ruptures during cell migration to limit DNA damage and cell death
Raab, M., Gentili, M., Belly, H. D., Thiam, H. R., Vargas, P., Jiménez, A. J., Lautenschläger, F., Voituriez, R., Lennon‐Duménil, A., Manel, N., et al. (2016) · Science · doi:10.1126/science.aad7611 · Cited by 946 · see citing works
Rausch, T., Jones, D. T. W., Zapatka, M., Stütz, A. M., Zichner, T., Weischenfeldt, J., Jäger, N., Remke, M., Shih, D., Northcott, P. A., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.013 · Cited by 865 · see citing works
Structure and variability of human chromosome ends.
de Lange, T., Shiue, L., Myers, R. M., Cox, D. R., Naylor, S. L., Killery, A. M., & Varmus, H. E. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.2.518 · Cited by 848 · see citing works
Self-citationTelomeres and telomerase in cancer
Artandi, S. E., & DePinho, R. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp268 · Cited by 823 · see citing works
Brown, J. P., Wei, W., & Sedivy, J. M. (1997) · Science · doi:10.1126/science.277.5327.831 · Cited by 804 · see citing works
Senescence Induced by Altered Telomere State, Not Telomere Loss
Karlseder, J., Smogorzewska, A., & de Lange, T. (2002) · Science · doi:10.1126/science.1069523 · Cited by 796 · see citing works
Regulation of Telomerase by Telomeric Proteins
Smogorzewska, A., & de Lange, T. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.071403.160049 · Cited by 796 · see citing works
A role for both RB and p53 in the regulation of human cellular senescence*1
SHAY, J. (1991) · Experimental Cell Research · doi:10.1016/0014-4827(91)90453-2 · Cited by 757 · see citing works
Catastrophic nuclear envelope collapse in cancer cell micronuclei
Hatch, E. M., Fischer, A. H., Deerinck, T. J., & Hetzer, M. W. (2013) · Cell · doi:10.1016/j.cell.2013.06.007 · Cited by 741 · see citing works
Chromothripsis and Kataegis Induced by Telomere Crisis
Maciejowski, J., Li, Y., Bosco, N., Campbell, P. J., & de Lange, T. (2015) · Cell · doi:10.1016/j.cell.2015.11.054 · Cited by 675 · see citing works
Self-citationRole of Telomeres and Telomerase in Aging and Cancer
Shay, J. W. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0062 · Cited by 668 · see citing works
Tetraploidy, aneuploidy and cancer
Ganem, N. J., Storchova, Z., & Pellman, D. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.02.011 · Cited by 668 · see citing works
Evolution of the cancer genome
Yates, L. R., & Campbell, P. J. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3317 · Cited by 645 · see citing works
Lovejoy, C. A., Li, W., Reisenweber, S., Thongthip, S., Bruno, J., de Lange, T., De, S., Petrini, J. H. J., Sung, P. A., Jasin, M., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002772 · Cited by 629 · see citing works
DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion
Celli, G. B., & de Lange, T. (2005) · Nature Cell Biology · doi:10.1038/ncb1275 · Cited by 623 · see citing works
RNA Editing Enzyme APOBEC1 and Some of Its Homologs Can Act as DNA Mutators
Harris, R. S., Petersen‐Mahrt, S. K., & Neuberger, M. S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00742-6 · Cited by 604 · see citing works
Telomerase activation by genomic rearrangements in high-risk neuroblastoma
Peifer, M., Hertwig, F., Roels, F., Dreidax, D., Gartlgruber, M., Menon, R., Krämer, A., Roncaioli, J. L., Sand, F., Heuckmann, J. M., et al. (2015) · Nature · doi:10.1038/nature14980 · Cited by 595 · see citing works
Extensive allelic variation and ultrashort telomeres in senescent human cells
Baird, D. M., Rowson, J., Wynford-Thomas, D., & Kipling, D. (2003) · Nature Genetics · doi:10.1038/ng1084 · Cited by 570 · see citing works
The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
Bell, R. J. A., Rube, H. T., Kreig, A., Mancini, A., Fouse, S. D., Nagarajan, R. P., Choi, S., Hong, C., He, D., Pekmezci, M., et al. (2015) · Science · doi:10.1126/science.aab0015 · Cited by 566 · see citing works
The Behavior in Successive Nuclear Divisions of a Chromosome Broken at Meiosis
McClintock, B. (1939) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.25.8.405 · Cited by 559 · see citing works
Santaguida, S., Tighe, A., D’Alise, A. M., Taylor, S. S., & Musacchio, A. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.201001036 · Cited by 538 · see citing works
Telomere dysfunction and evolution of intestinal carcinoma in mice and humans
Rudolph, K. L., Millard, M., Bosenberg, M. W., & DePinho, R. A. (2001) · Nature Genetics · doi:10.1038/88871 · Cited by 527 · see citing works
Harris, R. S., & Dudley, J. P. (2015) · Virology · doi:10.1016/j.virol.2015.03.012 · Cited by 518 · see citing works
Heaphy, C. M., Subhawong, A. P., Hong, S.-M., Goggins, M. G., Montgomery, E. A., Gabrielson, E., Netto, G. J., Epstein, J. I., Lotan, T. L., Westra, W. H., et al. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.06.018 · Cited by 516 · see citing works
Cohesin Cleavage by Separase Required for Anaphase and Cytokinesis in Human Cells
Hauf, S., Waizenegger, I. C., & Peters, J. (2001) · Science · doi:10.1126/science.1061376 · Cited by 503 · see citing works
TPP1 is a homologue of ciliate TEBP-β and interacts with POT1 to recruit telomerase
Xin, H., Liu, D., Wan, M., Safari, A., Kim, H., Sun, W., O’Connor, M. S., & Songyang, Z. (2007) · Nature · doi:10.1038/nature05469 · Cited by 486 · see citing works
Genome-wide analysis of noncoding regulatory mutations in cancer
Weinhold, N., Jacobsen, A., Schultz, N., Sander, C., & Lee, W. (2014) · Nature Genetics · doi:10.1038/ng.3101 · Cited by 484 · see citing works
Different telomere damage signaling pathways in human and mouse cells
Smogorzewska, A., & de Lange, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf433 · Cited by 482 · see citing works
Gomes, N. M. V., Ryder, O. A., Houck, M. L., Charter, S. J., Walker, W., Forsyth, N. R., Austad, S. N., Venditti, C., Pagel, M., Shay, J. W., et al. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00718.x · Cited by 464 · see citing works
Dewhurst, S. M., McGranahan, N., Burrell, R. A., Rowan, A., Gronroos, E. C., Endesfelder, D., Joshi, T., Mouradov, D., Gibbs, P., Ward, R. L., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0285 · Cited by 450 · see citing works
Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions
Ramirez, R. D., Morales, C. P., Herbert, B.-S., Rohde, J. M., Passons, C., Shay, J. W., & Wright, W. E. (2001) · Genes & Development · doi:10.1101/gad.859201 · Cited by 444 · see citing works
Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity
Gisselsson, D., Pettersson, L., Höglund, M., Heidenblad, M., Gorunova, L., Wiegant, J. C. A. G., Mertens, F., Cin, P. D., Mitelman, F., & Mandahl, N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090013497 · Cited by 438 · see citing works
The Causes and Consequences of Polyploidy in Normal Development and Cancer
Davoli, T., & de Lange, T. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154234 · Cited by 432 · see citing works
Gisselsson, D., Jonson, T., Petersén, Å., Strömbeck, B., Cin, P. D., Höglund, M., Mitelman, F., Mertens, F., & Mandahl, N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211357798 · Cited by 416 · see citing works
Chan, K., Roberts, S. A., Klimczak, L. J., Sterling, J. F., Saini, N., Malc, E. P., Kim, J., Kwiatkowski, D. J., Fargo, D. C., Mieczkowski, P. A., et al. (2015) · Nature Genetics · doi:10.1038/ng.3378 · Cited by 414 · see citing works
Roberts, S. A., Sterling, J. F., Thompson, C., Harris, S. F., Mav, D., Shah, R., Klimczak, L. J., Kryukov, G. V., Malc, E. P., Mieczkowski, P. A., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.03.030 · Cited by 414 · see citing works
TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors
Valentijn, L. J., Köster, J., Zwijnenburg, D. A., Hasselt, N. E., Sluis, P. V., Volckmann, R., van Noesel, M. M., George, R. E., Tytgat, G. A. M., Molenaar, J. J., et al. (2015) · Nature Genetics · doi:10.1038/ng.3438 · Cited by 398 · see citing works
POT1 loss-of-function variants predispose to familial melanoma
Robles-Espinoza, C. D., Harland, M., Ramsay, A. J., Aoude, L. G., Quesada, V., Ding, Z., Pooley, K. A., Pritchard, A. L., Tiffen, J. C., Petljak, M., et al. (2014) · Nature Genetics · doi:10.1038/ng.2947 · Cited by 391 · see citing works
Telomerase activity: a prevalent marker of malignant human prostate tissue.
Sommerfeld, H. J., Meeker, A. K., Piatyszek, M. A., Bova, G. S., Shay, J. W., & Coffey, D. S. (1996) · PubMed · Cited by 391 · see citing works
Telomere dynamics in an immortal human cell line.
Murnane, J. P., Sabatier, L., Marder, B. A., & Morgan, W. F. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06822.x · Cited by 381 · see citing works
Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis.
Shih, I., Zhou, W. J., Goodman, S. N., Christoph Lengauer, C., Kinzler, K. W., & Vogelstein, B. (2001) · PubMed · Cited by 381 · see citing works
Finding the end: recruitment of telomerase to telomeres
Nandakumar, J., & Cech, T. R. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3505 · Cited by 378 · see citing works
DNA Ligase IV-Dependent NHEJ of Deprotected Mammalian Telomeres in G1 and G2
Smogorzewska, A., Karlseder, J., Holtgreve-Grez, H., Jauch, A. S., & de Lange, T. (2002) · Current Biology · doi:10.1016/s0960-9822(02)01179-x · Cited by 377 · see citing works
Short Dysfunctional Telomeres Impair Tumorigenesis in the INK4aΔ2/3 Cancer-Prone Mouse
Greenberg, R. A., Chin, L., Femino, A., Lee, K.-H., Gottlieb, G. J., Singer, R. H., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80761-8 · Cited by 367 · see citing works
In situ analyses of genome instability in breast cancer
Chin, K., de Solorzano, C. O., Knowles, D., Jones, A., Chou, W., Rodriguez, E. G., Kuo, W.-L., Ljung, B.-M., Chew, K., Myambo, K., et al. (2004) · Nature Genetics · doi:10.1038/ng1409 · Cited by 361 · see citing works
Galipeau, P. C., Cowan, D., Sanchez, C. A., Barrett, M. T., Emond, M. J., Levine, D. S., Rabinovitch, P. S., & Reid, B. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7081 · Cited by 360 · see citing works
The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity
Nandakumar, J., Bell, C., Weidenfeld, I., Zaug, A. J., Leinwand, L. A., & Cech, T. R. (2012) · Nature · doi:10.1038/nature11648 · Cited by 351 · see citing works
Miyake, Y., Nakamura, M., Nabetani, A., Shimamura, S., Tamura, M., Yonehara, S., Saito, M., & Ishikawa, F. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.08.009 · Cited by 350 · see citing works
Analysis of Loss of Heterozygosity in 399 Premalignant Breast Lesions at 15 Genetic Loci
O'Connell, P., Pekkel, V., Allred, D. C., Fuqua, S. A. W., Osborne, C. K., & Clark, G. M. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.9.697 · Cited by 339 · see citing works
Telomerase: An RNP Enzyme Synthesizes DNAPreprint
Blackburn, E. H., & Collins, K. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003558 · Cited by 333 · see citing works
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma
NCI DCEG Cancer Sequencing Working Group, Shi, J., Laboratory, N. D. C. G. R., French Familial Melanoma Study Group, Yang, X. R., Ballew, B., Rotunno, M., Calista, D., Fargnoli, M. C., Ghiorzo, P., et al. (2014) · Nature Genetics · doi:10.1038/ng.2941 · Cited by 331 · see citing works
Telomeric 3′ Overhangs Derive from Resection by Exo1 and Apollo and Fill-In by POT1b-Associated CST
Wu, P. V., Takai, H., & de Lange, T. (2012) · Cell · doi:10.1016/j.cell.2012.05.026 · Cited by 322 · see citing works
Celli, G. B., Denchi, E. L., & de Lange, T. (2006) · Nature Cell Biology · doi:10.1038/ncb1444 · Cited by 320 · see citing works
Telomere length homeostasis requires that telomerase levels are limiting
Cristofari, G., & Lingner, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600952 · Cited by 315 · see citing works
Short Telomeres Limit Tumor Progression In Vivo by Inducing Senescence
Feldser, D. M., & Greider, C. W. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.026 · Cited by 314 · see citing works
Break-induced replication: What is it and what is it for?
Llorente, B., Smith, C. E., & Symington, L. S. (2008) · Cell Cycle · doi:10.4161/cc.7.7.5613 · Cited by 313 · see citing works
Telomere Length Abnormalities Occur Early in the Initiation of Epithelial Carcinogenesis
Meeker, A. K., Hicks, J. L., Iacobuzio-Donahue, C. A., Montgomery, E. A., Westra, W. H., Chan, T. Y., Ronnett, B. M., & De Marzo, A. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0984-03 · Cited by 306 · see citing works
Human telomerase: biogenesis, trafficking, recruitment, and activationPreprint
Schmidt, J. C., & Cech, T. R. (2015) · Genes & Development · doi:10.1101/gad.263863.115 · Cited by 301 · see citing works
Persistent Telomere Damage Induces Bypass of Mitosis and Tetraploidy
Davoli, T., Denchi, E. L., & de Lange, T. (2010) · Cell · doi:10.1016/j.cell.2010.01.031 · Cited by 298 · see citing works
Self-citationSurovtseva, Y. V., Churikov, D., Boltz, K. A., Song, X., Lamb, J. C., Warrington, R. T., Leehy, K. A., Heacock, M. L., Price, C. M., & Shippen, D. E. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.017 · Cited by 296 · see citing works
The nature of telomere fusion and a definition of the critical telomere length in human cells
Capper, R., Britt-Compton, B., Tankimanova, M., Rowson, J., Letsolo, B., Man, S., Haughton, M., & Baird, D. M. (2007) · Genes & Development · doi:10.1101/gad.439107 · Cited by 294 · see citing works
Does a Sentinel or a Subset of Short Telomeres Determine Replicative Senescence?
Zou, Y., Sfeir, A., Gryaznov, S. M., Shay, J. W., & Wright, W. E. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-03-0207 · Cited by 293 · see citing works
<i>TERT</i> promoter mutations and telomerase reactivation in urothelial cancer
Borah, S., Xi, L., Zaug, A. J., Powell, N. M., Dancik, G. M., Cohen, S. B., Costello, J. C., Theodorescu, D., & Cech, T. R. (2015) · Science · doi:10.1126/science.1260200 · Cited by 292 · see citing works
Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia
Li, Y., Schwab, C. J., Ryan, S. L., Papaemmanuil, E., Robinson, H. M., Jacobs, P. A., Moorman, A. V., Dyer, S., Borrow, J., Griffiths, M., et al. (2014) · Nature · doi:10.1038/nature13115 · Cited by 279 · see citing works
Telomere Shortening Is Proportional to the Size of the G-rich Telomeric 3′-Overhang
Huffman, K. E., Levene, S. D., Tesmer, V. M., Shay, J. W., & Wright, W. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002843200 · Cited by 274 · see citing works
Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis
Nones, K., Waddell, N., Wayte, N., Patch, A., Bailey, P. J., Newell, F., Holmes, O., Fink, J. L., Quinn, M. C. J., Tang, Y., et al. (2014) · Nature Communications · doi:10.1038/ncomms6224 · Cited by 274 · see citing works
Boboilă, C., Alt, F. W., & Schwer, B. (2012) · Advances in immunology · doi:10.1016/b978-0-12-394300-2.00001-6 · Cited by 273 · see citing works
Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis.
Meeker, A. K., Hicks, J. L., Platz, E. A., March, G. E., Bennett, C., Delannoy, M. J., & Marzo, A. M. D. (2002) · PubMed · Cited by 271 · see citing works
Box H/ACA Small Ribonucleoproteins
Kiss, T., Fayet-Lebaron, E., & Jády, B. E. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.032 · Cited by 267 · see citing works
Tetraploidy and chromosomal instability are early events during cervical carcinogenesis
Olaharski, A. J., Sotelo, R., Solorza-Luna, G., Gonsebatt, M. E., Guzmán, P., Mohar, A., & Eastmond, D. A. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi218 · Cited by 264 · see citing works
Transient nuclear envelope rupturing during interphase in human cancer cells
Vargas, J. D., Hatch, E. M., Anderson, D. J., & Hetzer, M. W. (2012) · Nucleus · doi:10.4161/nucl.18954 · Cited by 263 · see citing works
Hara, E., Tsurui, H., Shinozaki, A., Nakada, S., & Oda, K. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91403-y · Cited by 260 · see citing works
Kinde, I., Munari, E., Faraj, S. F., Hruban, R. H., Schoenberg, M., Bivalacqua, T., Allaf, M., Springer, S., Wang, Y., Diaz, L. A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2498 · Cited by 253 · see citing works
Cancer-associated TERT promoter mutations abrogate telomerase silencing
Chiba, K., Johnson, J. Z., Vogan, J. M., Wagner, T., Boyle, J. M., & Hockemeyer, D. F. (2015) · eLife · doi:10.7554/elife.07918 · Cited by 253 · see citing works
Model for the genetic evolution of human solid tumors.
Shackney, S. E., Smith, C., Miller, B. W., Burholt, D. R., Murtha, K., Giles, H. R., Ketterer, D. M., & Pollice, A. A. (1989) · PubMed · Cited by 252 · see citing works
Telomere dysfunction provokes regional amplification and deletion in cancer genomes
O'Hagan, R. C., Chang, S., Maser, R. S., Mohan, R., Artandi, S. E., Chin, L., & DePinho, R. A. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00094-6 · Cited by 246 · see citing works
Davoli, T., & de Lange, T. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.03.044 · Cited by 242 · see citing works
TIN2-Tethered TPP1 Recruits Human Telomerase to Telomeres In Vivo
Abreu, E. B., Aritonovska, E., Reichenbach, P., Cristofari, G., Culp, B. R., Terns, R. M., Lingner, J., & Terns, M. P. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00240-10 · Cited by 240 · see citing works
TERT promoter mutations in cancer development
Heidenreich, B., Rachakonda, P. S., Hemminki, K., & Kumar, R. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.11.005 · Cited by 238 · see citing works
Significant Role for p16INK4a in p53-Independent Telomere-Directed Senescence
Jacobs, J. J. L., & de Lange, T. (2004) · Current Biology · doi:10.1016/j.cub.2004.12.025 · Cited by 237 · see citing works
Mangino, M., Hwang, S., Spector, T. D., Hunt, S. C., Kimura, M., Fitzpatrick, A. L., Christiansen, L., Petersen, I., Elbers, C. C., Harris, T. B., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds382 · Cited by 224 · see citing works
Break-Induced DNA ReplicationPreprint
Anand, R., Lovett, S. T., & Haber, J. E. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a010397 · Cited by 223 · see citing works
Ding, Z., Wu, C.-J., Jaskelioff, M., Ivanova, E., Kost-Alimova, M., Protopopov, A., Chu, G. C., Wang, G., Lu, X., Labrot, E. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.039 · Cited by 220 · see citing works
Kaste, S. C., Pratt, C. B., Cain, A. M., Jones-Wallace, D., & Rao, B. N. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991015)86:8 · Cited by 212 · see citing works
Molecular mechanisms of activity and derepression of alternative lengthening of telomeres
Pickett, H. A., & Reddel, R. R. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3106 · Cited by 203 · see citing works
Human Disease Phenotypes Associated With Mutations in TREX1
Rice, G., Rodero, M. P., & Crow, Y. J. (2015) · Journal of Clinical Immunology · doi:10.1007/s10875-015-0147-3 · Cited by 203 · see citing works
Shay, J. W., Wright, W. E., Brasiskyte, D., & Haegen, B. A. (1993) · PubMed · Cited by 201 · see citing works
Bignell, G. R., Santarius, T., Pole, J. C. M., Butler, A. P., Perry, J., Pleasance, E., Greenman, C., Menzies, A. H., Taylor, S., Edkins, S., et al. (2007) · Genome Research · doi:10.1101/gr.6522707 · Cited by 195 · see citing works
The Architecture and Evolution of Cancer Neochromosomes
Garsed, D. W., Marshall, O. J., Corbin, V. D. A., Hsu, A., Di Stefano, L., Schröder, J., Li, J., Feng, Z.-P., Kim, B. W., Kowarsky, M., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.010 · Cited by 194 · see citing works
Ma, C., Martin, S., Trask, B. J., & Hamlin, J. L. (1993) · Genes & Development · doi:10.1101/gad.7.4.605 · Cited by 192 · see citing works
Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk
Walsh, K. M., Codd, V., Smirnov, I. V., Rice, T., Decker, P. A., Hansen, H. M., Kollmeyer, T. M., Kosel, M., Molinaro, A. M., Mccoy, L. S., et al. (2014) · Nature Genetics · doi:10.1038/ng.3004 · Cited by 189 · see citing works
Stepwise RNP assembly at the site of H/ACA RNA transcription in human cells
Darzacq, X., Kittur, N. D., Roy, S., Shav‐Tal, Y., Singer, R. H., & Meier, U. T. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200601105 · Cited by 187 · see citing works
Telomere-related Genome Instability in Cancer
DE LANGE, T. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.032 · Cited by 182 · see citing works
Self-citationLin, T. T., Letsolo, B. T., Jones, R. E., Rowson, J., Pratt, G., Hewamana, S., Fegan, C., Pepper, C., & Baird, D. M. (2010) · Blood · doi:10.1182/blood-2010-02-272104 · Cited by 178 · see citing works
Biogenesis of telomerase ribonucleoproteins
Egan, E. D., & Collins, K. (2012) · RNA · doi:10.1261/rna.034629.112 · Cited by 177 · see citing works
Telomeres and chromosome instability
Murnane, J. P. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.05.030 · Cited by 174 · see citing works
A human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein
Höss, M., Robins, P., Naven, T. J. P., Pappin, D., SGOUROS, J. G., & Lindahl, T. L. (1999) · The EMBO Journal · doi:10.1093/emboj/18.13.3868 · Cited by 170 · see citing works
Lo, A. W. I., Sabatier, L., Fouladi, B., Pottier, G., Ricoul, M., & Mumane, J. P. (2002) · Neoplasia · doi:10.1038/sj.neo.7900267 · Cited by 169 · see citing works
A telomere-dependent DNA damage checkpoint induced by prolonged mitotic arrest
Hayashi, M., Cesare, A. J., Fitzpatrick, J. A. J., Denchi, E. L., & Karlseder, J. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2245 · Cited by 166 · see citing works
Stop pulling my strings — what telomeres taught us about the DNA damage response
Denchi, E. L., & Sfeir, A. J. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.43 · Cited by 166 · see citing works
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
Remke, M., Ramaswamy, V., Peacock, J., Shih, D. J. H., Koelsche, C., Northcott, P. A., Hill, N., Cavalli, F. M. G., Kool, M., Wang, X., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1198-2 · Cited by 164 · see citing works
Human CST has independent functions during telomere duplex replication and C-strand fill-in
Wang, F., Stewart, J., Kasbek, C., Zhao, Y., Wright, W., & Price, C. M. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.10.007 · Cited by 162 · see citing works
Sabatier, L., Ricoul, M., Pottier, G., & Murnane, J. P. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-04-0194 · Cited by 160 · see citing works
A Virus Causes Cancer by Inducing Massive Chromosomal Instability through Cell Fusion
Duelli, D. M., Padilla‐Nash, H. M., Berman, D. M., Murphy, K. M., Ried, T., & Lazebnik, Y. A. (2007) · Current Biology · doi:10.1016/j.cub.2007.01.049 · Cited by 157 · see citing works
Apollo Contributes to G Overhang Maintenance and Protects Leading-End Telomeres
Wu, P. V., van Overbeek, M., Rooney, S., & de Lange, T. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.031 · Cited by 154 · see citing works
Clarke, D. J., Johnson, R. T., & Downes, C. S. (1993) · Journal of Cell Science · doi:10.1242/jcs.105.2.563 · Cited by 141 · see citing works
Meeker, A. K., Hicks, J. L., Gabrielson, E., Strauss, W. M., De Marzo, A. M., & Argani, P. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63180-x · Cited by 140 · see citing works
A cell‐based model system links chromothripsis with hyperploidy
Mardin, B. R., Drainas, A. P., Waszak, S. M., Weischenfeldt, J., Isokane, M., Stütz, A. M., Raeder, B., Efthymiopoulos, T., Buccitelli, C., Segura‐Wang, M., et al. (2015) · Molecular Systems Biology · doi:10.15252/msb.20156505 · Cited by 140 · see citing works
Smith, K. A. B., Gorman, P. A., Stark, M. B., Groves, R. P., & Stark, G. R. (1990) · Cell · doi:10.1016/0092-8674(90)90417-d · Cited by 133 · see citing works
Chromothripsis: Chromosomes in Crisis
Jones, M. V., & Jallepalli, P. V. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.10.010 · Cited by 130 · see citing works
Cell death during crisis is mediated by mitotic telomere deprotection
Hayashi, M. T., Cesare, A. J., Rivera, T., & Karlseder, J. (2015) · Nature · doi:10.1038/nature14513 · Cited by 125 · see citing works
Long telomeres and cancer risk among 95 568 individuals from the general population
Rode, L., Nordestgaard, B. G., & Bojesen, S. E. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw179 · Cited by 120 · see citing works
Properties of Deoxyribonuclease III from Mammalian Tissues
Lindahl, T. L., Gally, J. A., & Edelman, G. M. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94303-6 · Cited by 119 · see citing works
Control of telomerase action at human telomeres
Hockemeyer, D. F., & Collins, K. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3083 · Cited by 118 · see citing works
Telomere Replication Stress Induced by POT1 Inactivation Accelerates Tumorigenesis
Pinzaru, A. M., Hom, R. A., Beal, A., Phillips, A. F., Ni, E., Cardozo, T. J., Nair, N., Choi, J., Wuttke, D. S., Sfeir, A. J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.008 · Cited by 114 · see citing works
Sexton, A. N., Regalado, S. G., Lai, C. S., Cost, G. J., O’Neil, C. M., Urnov, F. D., Gregory, P. D., Jaenisch, R., Collins, K., & Hockemeyer, D. F. (2014) · Genes & Development · doi:10.1101/gad.246819.114 · Cited by 109 · see citing works
Huang, C., Dai, X., & Chai, W. (2012) · Cell Research · doi:10.1038/cr.2012.132 · Cited by 102 · see citing works
Deregulated Aurora‐B induced tetraploidy promotes tumorigenesis
Nguyen, H. G., Makitalo, M., Yang, D., Chinnappan, D., Hilaire, C. S., & Ravid, K. (2009) · The FASEB Journal · doi:10.1096/fj.09-130963 · Cited by 101 · see citing works
Roger, L., Jones, R. E., Heppel, N. H., Williams, G. T., Sampson, J. R., & Baird, D. M. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt191 · Cited by 97 · see citing works
Telomere shortening in renal cell carcinoma.
Mehle, C., Ljungberg, B., & Roos, G. (1994) · PubMed · Cited by 97 · see citing works
Fouladi, B., Sabatier, L., Miller, D., Pottier, G., & Murnane, J. P. (2000) · Neoplasia · doi:10.1038/sj.neo.7900107 · Cited by 96 · see citing works
Lin, T. T., Norris, K., Heppel, N. H., Pratt, G., Allan, J. M., Allsup, D. J., Bailey, J. R., Cawkwell, L., Hills, R. K., Grimstead, J. W., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.13023 · Cited by 92 · see citing works
Machiela, M. J., Hsiung, C. A., Shu, X., Seow, W. J., Wang, Z., Matsuo, K., Hong, Y., Seow, A., Wu, C., Hosgood, H. D., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29393 · Cited by 90 · see citing works
Herbert, B., Wright, W. E., & Shay, J. W. (2001) · Breast Cancer Research · doi:10.1186/bcr288 · Cited by 88 · see citing works
Regulating telomere length from the inside out: the replication fork modelPreprint
Greider, C. W. (2016) · Genes & Development · doi:10.1101/gad.280578.116 · Cited by 88 · see citing works
Hamma, T., & Ferré-D’Amaré, A. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.076893 · Cited by 87 · see citing works
Human TEN1 Maintains Telomere Integrity and Functions in Genome-wide Replication Restart
Kasbek, C., Wang, F., & Price, C. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.493478 · Cited by 80 · see citing works
Maser, R. S., Wong, K., Sahin, E., Xia, H., Naylor, M. L., Hedberg, H. M., Artandi, S. E., & DePinho, R. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01354-06 · Cited by 79 · see citing works
Structure and Expression of the TREX1 and TREX2 3′→5′ Exonuclease Genes
Mazur, D. J., & Perrino, F. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010051200 · Cited by 75 · see citing works
Escape from Telomere-Driven Crisis Is DNA Ligase III Dependent
Jones, R. E., Oh, S., Grimstead, J. W., Zimbric, J., Roger, L., Heppel, N. H., Ashelford, K. E., Liddiard, K., Hendrickson, E. A., & Baird, D. M. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.007 · Cited by 74 · see citing works
Pampalona, J., Roscioli, E., Silkworth, W. T., Bowden, B., Genescà, A., Tusell, L., & Cimini, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147420 · Cited by 73 · see citing works
Ojha, J., Codd, V., Nelson, C. P., Samani, N. J., Smirnov, I. V., Madsen, N. R., Hansen, H. M., de Smith, A. J., Bracci, P. M., Wiencke, J. K., et al. (2016) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-1329 · Cited by 71 · see citing works
Frequency of TERT promoter mutations in primary tumors of the liver
Quaas, A., Oldopp, T., Tharun, L., Klingenfeld, C., Krech, T., Sauter, G., & Grob, T. J. (2014) · Virchows Archiv · doi:10.1007/s00428-014-1658-7 · Cited by 70 · see citing works
Qi, L., Strong, M. A., Karim, B. O., Armanios, M. Y., Huso, D. L., & Greider, C. W. (2003) · PubMed · Cited by 68 · see citing works
Schmutz, I., & de Lange, T. (2016) · Current Biology · doi:10.1016/j.cub.2016.01.056 · Cited by 66 · see citing works
Dai, X., Huang, C., Bhusari, A., Sampathi, S., Schubert, K. M., & Chai, W. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.156 · Cited by 65 · see citing works
Induced dicentric chromosome formation promotes genomic rearrangements and tumorigenesis
Gascoigne, K. E., & Cheeseman, I. M. (2013) · Chromosome Research · doi:10.1007/s10577-013-9368-6 · Cited by 65 · see citing works
The Shelterin TIN2 Subunit Mediates Recruitment of Telomerase to Telomeres
Frank, A. K., Tran, D. C., Qu, R. W., Stohr, B. A., Segal, D. J., & Xu, L. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005410 · Cited by 62 · see citing works
Deciphering the Code of the Cancer Genome: Mechanisms of Chromosome Rearrangement
Willis, N. A., Rass, E., & Scully, R. (2015) · Trends in cancer · doi:10.1016/j.trecan.2015.10.007 · Cited by 62 · see citing works
López, V., Barinova, N., Onishi, M., Pobiega, S., Pringle, J. R., Dubrana, K., & Marcand, S. (2015) · Genes & Development · doi:10.1101/gad.254664.114 · Cited by 62 · see citing works
Machiela, M. J., Lan, Q., Slager, S. L., Vermeulen, R. C. H., Teras, L. R., Camp, N. J., Cerhan, J. R., Spinelli, J. J., Wang, S. S., Nieters, A., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw027 · Cited by 58 · see citing works
Oh, S., Harvey, A., Zimbric, J., Wang, Y., Nguyen, T., Jackson, P. J., & Hendrickson, E. A. (2014) · DNA Repair · doi:10.1016/j.dnarep.2014.04.015 · Cited by 58 · see citing works
Telomere shortening in gastric carcinoma with aging despite telomerase activation
Furugori, E., Hirayama, R., Nakamura, K.-I., Kammori, M., Esaki, Y., & Takubo, K. (2000) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320000137 · Cited by 54 · see citing works
Telomere fusions in early human breast carcinoma
Tanaka, H., Abe, S., Huda, N., Tu, L., Beam, M. J., Grimes, B., & Gilley, D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120062109 · Cited by 52 · see citing works
Liddiard, K., Ruis, B. L., Takasugi, T., Harvey, A., Ashelford, K. E., Hendrickson, E. A., & Baird, D. M. (2016) · Genome Research · doi:10.1101/gr.200840.115 · Cited by 47 · see citing works
Telomere fusion threshold identifies a poor prognostic subset of breast cancer patients
Simpson, K., Jones, R. E., Grimstead, J. W., Hills, R., Pepper, C., & Baird, D. M. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.02.003 · Cited by 46 · see citing works
Telomeric fusions in cultured human fibroblasts as a source of genomic instability
Riboni, R., Casati, A., Nardo, T., Zaccaro, E., Ferretti, L., Nuzzo, F., & Mondello, C. (1997) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00248-8 · Cited by 45 · see citing works
Telomere Dynamics in a Human Cancer Cell Line
Sprung, C. N., Sabatier, L., & Murnane, J. P. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4293 · Cited by 36 · see citing works
Telomere fusion to chromosome breaks reduces oncogenic translocations and tumour formation
Qi, L., Strong, M. A., Karim, B. O., Huso, D. L., & Greider, C. W. (2005) · Nature Cell Biology · doi:10.1038/ncb1276 · Cited by 32 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Kumari, R., & Jat, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645593 · Cited by 1,622 · see citing works
Shelterin-Mediated Telomere Protection
de Lange, T. (2018) · Annual Review of Genetics · doi:10.1146/annurev-genet-032918-021921 · Cited by 816 · see citing works
Self-citationTelomeres: history, health, and hallmarks of aging
Chakravarti, D., LaBella, K. A., & DePinho, R. A. (2021) · Cell · doi:10.1016/j.cell.2020.12.028 · Cited by 637 · see citing works
Rodriguez-Martin, B., Alvarez, E. G., Baez-Ortega, A., Zamora, J., Supek, F., Demeulemeester, J., Santamarina, M., Ju, Y. S., Temes, J., Garcia-Souto, D., et al. (2020) · Nature Genetics · doi:10.1038/s41588-019-0562-0 · Cited by 451 · see citing works
Chronic inflammation and the hallmarks of aging
Baechle, J. J., Chen, N., Makhijani, P., Winer, S., Furman, D., & Winer, D. A. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101755 · Cited by 471 · see citing works
Autophagic cell death restricts chromosomal instability during replicative crisis
Nassour, J., Radford, R., Correia, A., Fusté, J. M., Schoell, B., Jauch, A., Shaw, R. J., & Karlseder, J. (2019) · Nature · doi:10.1038/s41586-019-0885-0 · Cited by 429 · see citing works
Mechanisms generating cancer genome complexity from a single cell division error
Umbreit, N. T., Zhang, C.-Z., Lynch, L. D., Blaine, L. J., Cheng, A. M., Tourdot, R., Sun, L., Almubarak, H. F., Judge, K., Mitchell, T. J., et al. (2020) · Science · doi:10.1126/science.aba0712 · Cited by 439 · see citing works
Aging of the cells: Insight into cellular senescence and detection Methods.
Mohamad Kamal, N. S., Safuan, S., Shamsuddin, S., & Foroozandeh, P. (2020) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2020.151108 · Cited by 287 · see citing works
Targeted and Persistent 8-Oxoguanine Base Damage at Telomeres Promotes Telomere Loss and Crisis
Fouquerel, E., Barnes, R. P., Uttam, S., Watkins, S. C., Bruchez, M. P., & Opresko, P. L. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.04.024 · Cited by 275 · see citing works
Immuno-genomic landscape of osteosarcoma
Wu, C.-C., Beird, H. C., Andrew Livingston, J., Advani, S., Mitra, A., Cao, S., Reuben, A., Ingram, D., Wang, W.-L., Ju, Z., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14646-w · Cited by 251 · see citing works
Shay, J. W. (2018) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.12.001 · Cited by 174 · see citing works
Roles of telomere biology in cell senescence, replicative and chronological ageing
Liu, J., Wang, L., Wang, Z., & Liu, J.-P. (2019) · Cells · doi:10.3390/cells8010054 · Cited by 164 · see citing works
Beginning at the ends: telomeres and human disease
Savage, S. A. (2018) · F1000Research · doi:10.12688/f1000research.14068.1 · Cited by 124 · see citing works
Integrating the DNA damage and protein stress responses during cancer development and treatment
Gorgoulis, V. G., Pefani, D., Pateras, I. S., & Trougakos, I. P. (2018) · The Journal of Pathology · doi:10.1002/path.5097 · Cited by 108 · see citing works
Alidousty, C., Baar, T., Martelotto, L. G., Heydt, C., Wagener, S., Fassunke, J., Duerbaum, N., Scheel, A. H., Frank, S., Holz, B., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5110 · Cited by 69 · see citing works
Genomics and the Immune Landscape of Osteosarcoma
Wu, C.-C., & Livingston, J. A. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-43085-6_2 · Cited by 58 · see citing works
Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy
Nikolouzakis, T. K., Chrysos, E., Docea, A. O., Fragkiadaki, P., Souglakos, J., Tsiaoussis, J., & Tsatsakis, A. (2024) · Cancers · doi:10.3390/cancers16111995 · Cited by 37 · see citing works
- Authors
- Maciejowski, J., & de Lange, T.
- Affiliations
- Rockefeller University (US)
- ORCID
- Maciejowski, John
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2017-01-18
- Volume
- 18
- Issue
- 3
- Pages
- 175-186
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- PMC
- PMC5589191
- OpenAlex
- W2577194681
- Cited by
- 745
- References
- 185
- Citations by year
- 2026: 45 · 2025: 84 · 2024: 107 · 2023: 68 · 2022: 79 · 2021: 101 · 2020: 94 · 2019: 60 · 2018: 75 · 2017: 30 · 2015: 1
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Update notices
- correction (2019-02-28)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R56AG016642, R01AG016642)
- National Cancer Institute (R01CA181090, K99CA212290, R00CA212290)
- Topics
- Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- telomeres, telomere shortening, telomere crisis, tumor suppression, genomic instability, chromothripsis, kataegis, tetraploidization, ATM kinase, ATR kinase, proliferation arrest, chromosomal rearrangements, carcinogenesis
- MeSH terms
- Chromothripsis, Humans, Neoplasms, Telomere, Telomerase, Genomic Instability, Telomere Shortening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review